✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-023 min read

Ozempic vs Mounjaro: What's the Difference?

Both are diabetes medications used for weight, but different drugs. The honest comparison.

An elegant studio portrait in a calm, reflective mood

The short answer

Ozempic is semaglutide and Mounjaro is tirzepatide. Both are FDA-approved to treat type 2 diabetes (not for weight loss specifically), and both reduce appetite, so both are sometimes used off-label for weight. Mounjaro works on two hormone pathways; Ozempic on one.

Quick comparison

FeatureOzempicMounjaro
Active ingredientSemaglutideTirzepatide
MakerNovo NordiskEli Lilly
FDA-approved forType 2 diabetesType 2 diabetes
How it is takenInjectionInjection
Hormone pathwaysOneTwo
Weight-loss-approved versionWegovyZepbound
At New Hope Weight LossNot dispensed; compounded semaglutide offered from $166 a monthNot dispensed; compounded tirzepatide offered from $233 a month

For weight loss

The weight-loss-approved versions are Wegovy (semaglutide) and Zepbound (tirzepatide). In trials of the weight-loss doses, tirzepatide produced larger average loss (about 20.9% in SURMOUNT-1, PMID 35658024) than semaglutide (about 14.9% in STEP 1, PMID 33567185).

Ready to start?

$199 Skeptics' Trial, see if it works for you

One-time $199 trial with physician evaluation and, only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient's location, one month of compounded semaglutide; the pharmacy confirms packaging and shipping details before fulfillment. No long-term commitment. Standard care starts with a $119 physician review; medication is separate, and compounded semaglutide programs start at $166/month.

Start the 30-day trial

How this relates to what we offer

We do not dispense Ozempic or Mounjaro. The dispensing pharmacy label identifies the compounded preparation as semaglutide or tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location. In person in Orange County and by telehealth for eligible patients in California.

Ready for an honest, physician-supervised plan?

A $119 review with Dr. Sharma is the first step, no pressure. Take the 2-minute quiz or call us.

Take the free 2-minute quiz or call (657) 837-3342

Frequently asked questions

Are Ozempic and Mounjaro the same?

No. Ozempic is semaglutide; Mounjaro is tirzepatide. Both are FDA-approved for type 2 diabetes and both reduce appetite, but they are different molecules.

Which is better for weight loss?

The weight-approved versions are Wegovy and Zepbound. Tirzepatide produced larger average loss in trials. The right choice depends on your situation and is a physician decision.

Can you use Ozempic or Mounjaro for weight loss?

They are diabetes drugs sometimes used off-label by prescription. The on-label weight versions are Wegovy and Zepbound.

Is compounded the same as Ozempic or Mounjaro?

No. The dispensing pharmacy label identifies the compounded preparation as semaglutide or tirzepatide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary. We never claim they are the brand.

What does New Hope offer?

Physician-supervised compounded semaglutide ($166/mo) or tirzepatide ($233/mo) after a $119 review, with honest framing.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Not ready to start? Get the details by email.

Pricing, how it works, and what to expect, sent to your inbox. No pressure, unsubscribe anytime.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.